CS
CBIO

Credit Suisse’s Crescent Biopharma CBIO Stock Holding History

Credit Suisse’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-308
Closed -$133K – 4231
2019
Q3 		$133K Buy
308
+78
+34% +$50.2K ﹤0.01% 3937
2019
Q2 		$274K Sell
230
-15
-6% -$17.9K ﹤0.01% 3720
2019
Q1 		$306K Sell
245
-137
-36% -$157K ﹤0.01% 3587
2018
Q4 		$362K Buy
382
+70
+22% +$84.2K ﹤0.01% 3425
2018
Q3 		$449K Sell
312
-105
-25% -$159K ﹤0.01% 3360
2018
Q2 		$674K Sell
417
-409
-50% -$703K ﹤0.01% 3276
2018
Q1 		$1.34M Buy
826
+707
+594% +$1.47M ﹤0.01% 2749
2017
Q4 		$200K Buy
+119
New +$157K ﹤0.01% 3747
2017
Q3 		– Sell
-171
Closed -$191K – 4208
2017
Q2 		$191K Buy
+171
New +$141K ﹤0.01% 3630
2014
Q3 		– Sell
-101
Closed -$85K – 4513
2014
Q2 		$85K Buy
+101
New +$101K ﹤0.01% 4560

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return